Skip to main content
. 2019 Mar 12;17:9. doi: 10.1186/s13053-019-0108-6

Table 2.

Detailed data of the six patients with LOE of MMR proteins

Nr Sex Age(years) Site Size Pathology Pattern of MMR protein loss Mutation Amino acid change Clinical significance of mutation Family history of cancer
1. F 45 rectum 1 .2cm tubulovillous adenoma with high-grade dysplasia MSH2MSH6 MSH6 deletion of exon7 unknown possibly pathogenicity No tumors in first- or second-degree
2. F 65 sigmoid colon 0.6 cm tubular adenoma with low-grade dysplasia MSH2 negative NA NA No tumors in first- or second-degree
3. M 58 transverse colon 3 cm tubular adenoma with high –grade dysplasia MLH1PMS2 Not detected NA NA unknown
4. M 48 rectum 1 .5cm tubular adenoma,malignant MSH2 c.181C > T (NM_000251.2) p.Gln61Ter pathological No tumors in first- or second-degree
5. M 48 transverse colon 0 .8cm tubular adenoma with low -grade dysplasia MSH2MSH6 MSH2c.842C > G (NM_000251.2) p.Ser281Ter pathological Father died of colon cancer at the age of 58;two uncles with colon cancer
6. M 39 ascending colon 3 .5cm tubular adenoma with low–grade dysplasia MSH2 c.1168C > T (NM_000251.2) p.Leu390Phe benign variant Four uncles with colorectal cancer